SILIQUINI, NICCOLO'
SILIQUINI, NICCOLO'
SCIENZE MEDICHE
Atopic dermatitis, dupilumab and cancers: a case series
2021-01-01 Siliquini N.; Giura M.T.; Viola R.; Ribero S.; Panzone M.; Dapavo P.; Fierro M.T.; Ortoncelli M.; Quaglino P.
Combination of dermabrasion and Apremilast for Hailey-Hailey disease
2021-01-01 Siliquini, Niccolò; Deboli, Tommaso; Marchetti Cautela, Jennifer; Mangia, Antongiulio; Fraccalvieri, Marco; Dapavo, Paolo; Quaglino, Pietro; Ribero, Simone
Comparison of Secukinumab and Ixekizumab in psoriasis: a real-life cohort study on the efficacy and drug survival of 445 patients
2022-01-01 Cariti, C; Dapavo, P; Mastorino, L; Ortoncelli, M; Siliquini, N; Merli, M; Avallone, G; Giordano, S; Fabrizio, R; Susca, S; Verrone, A; Stroppiana, E; Quaglino, P; Ribero, S
Cupping in herpes zoster infection
2022-01-01 Burzi, Lorenza; Repetto, Federica; Zenone, Mattia; Siliquini, Niccolò; Panzone, Michele; Ribero, Simone
Dupilumab in HIV-positive patients with atopic dermatitis: A long-term follow-up patient and a literature review
2021-01-01 Avallone G.; Trunfio M.; Giura M.T.; Siliquini N.; Viola R.; Orofino G.; Mastorino L.; Ortoncelli M.; Quaglino P.; Ribero S.
Effectiveness and Safety of Dupilumab for the Treatment of Atopic Dermatitis in Adult Cohort: a Real-Life Italian Tertiary Centre Experience.
2022-01-01 Ribero S, Giura MT, Viola R, Ramondetta A, Siliquini N, Cardone P, Tonella L, Quaglino P, Dapavo P, Panzone M, Ortoncelli M, Fierro MT.
Effectiveness of Brodalumab on Scalp, Palmoplantar, and Genital Psoriasis: A Descriptive Pilot Study
2023-01-01 Mastorino L.; Celoria V.; Macagno N.; Cariti C.; Susca S.; Siliquini N.; Ortoncelli M.; Stroppiana E.; Verrone A.; Burzi L.; Quaglino P.; Ribero S.; Dapavo P.
Effectiveness of Secukinumab in the treatment of moderate–severe hidradenitis suppurativa: results from an Italian multicentric retrospective study in a real-life setting
2021-01-01 Ribero S.; Ramondetta A.; Fabbrocini G.; Bettoli V.; Potenza C.; Chiricozzi A.; Licciardello M.; Marzano A.V.; Bianchi L.; Rozzo G.; Fania L.; Marasca C.; Odorici G.; Mambrin A.; Moltrasio C.; Caposiena Caro R.D.; Skroza N.; Quaglino P.; Siliquini N.; Dapavo P.
Efficacy of switching from adalimumab originator to adalimumab biosimilar in moderate to severe psoriasis patients: A Real-life experience in a tertiary referral centre
2021-01-01 Gallo G.; Rostagno E.; Siliquini N.; Stroppiana E.; Verrone A.; Ortoncelli M.; Quaglino P.; Dapavo P.; Ribero S.
Efficacy, safety, and drug survival of IL-23, IL-17, and TNF-alpha inhibitors for psoriasis treatment: a retrospective study
2021-01-01 Dapavo P.; Siliquini N.; Mastorino L.; Avallone G.; Merli M.; Agostini A.; Cariti C.; Viola R.; Stroppiana E.; Verrone A.; Ortoncelli M.; Quaglino P.; Ribero S.
Head and neck severity index is associated to a significant worsening of quality of life in atopic dermatitis patients
2021-01-01 Ribero S.; Puglisi B.; Giura M.T.; Viola R.; Siliquini N.; Quaglino P.; Ortoncelli M.
Misuse, consequences and phototoxic skin-related effects of Rutaceae: a comprehensive literature review
2022-01-01 Avallone, Gianluca; Mastorino, Luca; Agostini, Andrea; Merli, Martina; Siliquini, Niccolò; Rubatto, Marco; Fierro, Maria Teresa; Ribero, Simone; Quaglino, Pietro
Patients with psoriasis resistant to multiple biological therapies: characteristics and definition of a difficult-to-treat population
2022-01-01 Mastorino L.; Roccuzzo G.; Dapavo P.; Siliquini N.; Avallone G.; Rubatto M.; Merli M.; Agostini A.; Ribero S.; Quaglino P.
Risankizumab shows high efficacy and maintenance in improvement of response until week 52
2022-01-01 Mastorino L.; Susca S.; Megna M.; Siliquini N.; Quaglino P.; Ortoncelli M.; Avallone G.; Rubatto M.; Fabbrocini G.; Dapavo P.; Ribero S.
Ruta graveolens phytophotodermatìtis
2021-01-01 Avallone G.; Mastorino L.; Agostini A.; Merli M.; Siliquini N.; Rubatto M.; Fierro M.T.; Ribero S.; Quaglino P.
Seven cancer patients receiving guselkumab for treatment of moderate-to-severe psoriasis
2022-01-01 Mastorino L.; Siliquini N.; Avallone G.; Ortoncelli M.; Quaglino P.; Dapavo P.; Ribero S.
Toxic epidermal necrolysis and role of immune dysregulation in a patient affected by coronavirus disease
2021-01-01 Parietti, Michele; Siliquini, Niccolò; Ortoncelli, Michela; Dapavo, Paolo; Stella, Maurizio; Verrua, Roberta; Ribero, Simone; Quaglino, Pietro
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Atopic dermatitis, dupilumab and cancers: a case series | 2021 | Siliquini N.; Giura M.T.; Viola R.; Ribero S.; Panzone M.; Dapavo P.; Fierro M.T.; Ortoncelli M.; Quaglino P. | |
| Combination of dermabrasion and Apremilast for Hailey-Hailey disease | 2021 | Siliquini, Niccolò; Deboli, Tommaso; Marchetti Cautela, Jennifer; Mangia, Antongiulio; Fraccalvieri, Marco; Dapavo, Paolo; Quaglino, Pietro; Ribero, Simone | |
| Comparison of Secukinumab and Ixekizumab in psoriasis: a real-life cohort study on the efficacy and drug survival of 445 patients | 2022 | Cariti, C; Dapavo, P; Mastorino, L; Ortoncelli, M; Siliquini, N; Merli, M; Avallone, G; Giordano, S; Fabrizio, R; Susca, S; Verrone, A; Stroppiana, E; Quaglino, P; Ribero, S | |
| Cupping in herpes zoster infection | 2022 | Burzi, Lorenza; Repetto, Federica; Zenone, Mattia; Siliquini, Niccolò; Panzone, Michele; Ribero, Simone | |
| Dupilumab in HIV-positive patients with atopic dermatitis: A long-term follow-up patient and a literature review | 2021 | Avallone G.; Trunfio M.; Giura M.T.; Siliquini N.; Viola R.; Orofino G.; Mastorino L.; Ortoncelli M.; Quaglino P.; Ribero S. | |
| Effectiveness and Safety of Dupilumab for the Treatment of Atopic Dermatitis in Adult Cohort: a Real-Life Italian Tertiary Centre Experience. | 2022 | Ribero S, Giura MT, Viola R, Ramondetta A, Siliquini N, Cardone P, Tonella L, Quaglino P, Dapavo P, Panzone M, Ortoncelli M, Fierro MT. | |
| Effectiveness of Brodalumab on Scalp, Palmoplantar, and Genital Psoriasis: A Descriptive Pilot Study | 2023 | Mastorino L.; Celoria V.; Macagno N.; Cariti C.; Susca S.; Siliquini N.; Ortoncelli M.; Stroppiana E.; Verrone A.; Burzi L.; Quaglino P.; Ribero S.; Dapavo P. | |
| Effectiveness of Secukinumab in the treatment of moderate–severe hidradenitis suppurativa: results from an Italian multicentric retrospective study in a real-life setting | 2021 | Ribero S.; Ramondetta A.; Fabbrocini G.; Bettoli V.; Potenza C.; Chiricozzi A.; Licciardello M.; Marzano A.V.; Bianchi L.; Rozzo G.; Fania L.; Marasca C.; Odorici G.; Mambrin A.; Moltrasio C.; Caposiena Caro R.D.; Skroza N.; Quaglino P.; Siliquini N.; Dapavo P. | |
| Efficacy of switching from adalimumab originator to adalimumab biosimilar in moderate to severe psoriasis patients: A Real-life experience in a tertiary referral centre | 2021 | Gallo G.; Rostagno E.; Siliquini N.; Stroppiana E.; Verrone A.; Ortoncelli M.; Quaglino P.; Dapavo P.; Ribero S. | |
| Efficacy, safety, and drug survival of IL-23, IL-17, and TNF-alpha inhibitors for psoriasis treatment: a retrospective study | 2021 | Dapavo P.; Siliquini N.; Mastorino L.; Avallone G.; Merli M.; Agostini A.; Cariti C.; Viola R.; Stroppiana E.; Verrone A.; Ortoncelli M.; Quaglino P.; Ribero S. | |
| Head and neck severity index is associated to a significant worsening of quality of life in atopic dermatitis patients | 2021 | Ribero S.; Puglisi B.; Giura M.T.; Viola R.; Siliquini N.; Quaglino P.; Ortoncelli M. | |
| Misuse, consequences and phototoxic skin-related effects of Rutaceae: a comprehensive literature review | 2022 | Avallone, Gianluca; Mastorino, Luca; Agostini, Andrea; Merli, Martina; Siliquini, Niccolò; Rubatto, Marco; Fierro, Maria Teresa; Ribero, Simone; Quaglino, Pietro | |
| Patients with psoriasis resistant to multiple biological therapies: characteristics and definition of a difficult-to-treat population | 2022 | Mastorino L.; Roccuzzo G.; Dapavo P.; Siliquini N.; Avallone G.; Rubatto M.; Merli M.; Agostini A.; Ribero S.; Quaglino P. | |
| Risankizumab shows high efficacy and maintenance in improvement of response until week 52 | 2022 | Mastorino L.; Susca S.; Megna M.; Siliquini N.; Quaglino P.; Ortoncelli M.; Avallone G.; Rubatto M.; Fabbrocini G.; Dapavo P.; Ribero S. | |
| Ruta graveolens phytophotodermatìtis | 2021 | Avallone G.; Mastorino L.; Agostini A.; Merli M.; Siliquini N.; Rubatto M.; Fierro M.T.; Ribero S.; Quaglino P. | |
| Seven cancer patients receiving guselkumab for treatment of moderate-to-severe psoriasis | 2022 | Mastorino L.; Siliquini N.; Avallone G.; Ortoncelli M.; Quaglino P.; Dapavo P.; Ribero S. | |
| Toxic epidermal necrolysis and role of immune dysregulation in a patient affected by coronavirus disease | 2021 | Parietti, Michele; Siliquini, Niccolò; Ortoncelli, Michela; Dapavo, Paolo; Stella, Maurizio; Verrua, Roberta; Ribero, Simone; Quaglino, Pietro |